Alessia Lodi

机构：The University of Texas at Austin · ORCID：0000-0002-2104-5713

发表论文 170 篇 · 总被引 4834 次 · h-index 33

代表论文

• Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial (2024 · Nature Communications · 被引 44)
• Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses (2024 · Nature Cancer · 被引 38)
• Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination Therapy (2025 · International Journal of Molecular Sciences · 被引 7)
• An in vivo “turning model” reveals new RanBP9 interactions in lung macrophages (2025 · Cell Death Discovery · 被引 4)
• RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation (2025 · Journal of Experimental & Clinical Cancer Research · 被引 3)
• Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations (2024 · Frontiers in Oncology · 被引 2)